Intensified program including Bendamustine followed by PBSC mobilization and high dose therapy and autograft for patients with relapsed or resistant CD 20+ Follicular Non Hodgkin Lymphoma: a multicenter, pivotal GITIL study.
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Bendamustine (Primary) ; Oxaliplatin
- Indications Follicular lymphoma
- Focus Adverse reactions
- Acronyms GITIL
Most Recent Events
- 20 Jul 2011 New trial record